CIPO Patents = 1

EPO Patents = 3

Forward Citations = 102

Loading Chart...

2 inventors (with patents filed for the assignee):

Grayson B Lipford (6 out of 23 patents)

Charles M Zepp (6 out of 57 patents)

6 patents: Sort by Forward Citations

1. 10117875 - Immune system modulators (2018-11-06),

2. 9873694 - Imidazole quinoline-based immune system modulators (2018-01-23),

3. 9637489 - Immune system modulators (2017-05-02),

4. 9359361 - Immune system modulators (2016-06-07),

5. 9353115 - Immune system modulators (2016-05-31),

6. 9126996 - Immune system modulators (2015-09-08),

Janus Biotherapeutics, Inc. is a biotechnology company specializing in the development of innovative therapeutics for autoimmune diseases. Our cutting-edge research focuses on targeting the Janus kinase (JAK) pathway to modulate immune response and improve patient outcomes. With a team of experienced scientists and industry experts, we are dedicated to advancing novel treatments that address unmet medical needs in the field of autoimmune disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#11 in Wellesley, MA

#2,474 in Massachusetts

#43,823 in US

Wellesley, MA, United States of America

Janus Biotherapeutics, Inc.

Forward Citations = 102

2 inventors:

Grayson B Lipford (6 out of 23 patents)

Charles M Zepp (6 out of 57 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com